InstaLax Polyethylene Glycol 3350 · POLYETHYLENE GLYCOL 3350 17 g/17g · Powder, For Solution · Oral · Sun Pharmaceutical Industries, Inc.
NDC 51672-2104-03 · 765 g in 1 CAN · ANDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. Put together: worth watching — several of the pressures that precede supply trouble are present at once.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Sun Pharmaceutical Industries, Inc. | POLYETHYLENE GLYCOL 3350 17 g/17g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Polyethylene Glycol 3350 — NDC 51672-2104-03," retrieved September 3, 2026, https://drugdashboards.com/drug/51672210403.
Free to cite with attribution — see how the data is put together.